Furthermore, the pan-cancer analysis of the mutation shows that E76K located at the allosteric site of SHP2 is implicated in not only lung cancer but colon adenocarcinoma, which suggests potentially extensive involvement of SHP2 in tumorigenesis and cancer progression for these individual types. Here, PTPN11 is linked to cancer.